This prospective, sequential dose-finding clinical observational study aims to estimate the median effective concentration (EC50) and the 95% effective concentration (EC95) of liposomal bupivacaine for ultrasound-guided femoral nerve block. Sensory and motor block endpoints are evaluated separately at 30 minutes after block placement using a modified up-and-down (sequential allocation) design, with trial termination after eight reversal points.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
EC50 and EC95 for femoral nerve sensory block
Timeframe: 30 minutes after femoral nerve block placement
EC50 and EC95 for femoral nerve motor block
Timeframe: 30 minutes after femoral nerve block placement